Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01740570
Brief Title: Phase I/II Cabazitaxel for Recurrent Malignant Glioma

First Submitted : November 30, 2012
First Submitted that Met QC Criteria : November 30, 2012
First Posted : December 4, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : January 17, 2018
Last Update Posted : January 19, 2018